(Q74225407)
Statements
A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function (English)
Rubenstein RC
1 February 1998
scientific article published on 01 February 1998